March 5, 2018 / 7:25 AM / 6 months ago

BRIEF-Fusion Antibodies Says At Least 40 Pct Revenue Growth Expected​ in FY

March 5 (Reuters) - Fusion Antibodies Plc:

* ‍FOR YEAR ENDING 31 MARCH 2018 AT LEAST 40% REVENUE GROWTH EXPECTED​

* ‍REVENUE FOR FULL YEAR 2017/18 IS BEHIND MARKET EXPECTATIONS​

* ‍CONTINUE TO HAVE POSITIVE OUTLOOK FOR 2018/19 IN LINE WITH EXPECTATIONS.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below